Skip to main content
Clinical Trials/RBR-2x86dc
RBR-2x86dcRecruiting未知

A retrospective, observational study to assess the rate of hospitalization inpatients with Schizophrenia treated one year before with oral Antipsychotics andone year after with long acting injectable Atypical Atipsychotics - REALAI

niversidade Federal de São Paulo - UNIFESP/EPM0 sitesStarted: April 15, 2016Last updated:

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18Y to 55Y (—)

Inclusion Criteria

  • Out-Patients with the main diagnosis of schizophrenia; only clinical records with complete information during the 2 years period
  • selected for data analysis will be included; patients treated with oral antipsychotics then switched to long acting injectable atypical due to poor adherence, lack of efficacy (no significant symptom reduction, judged by physician, at maximum recommended dose of an antipsychotic for 6 weeks), patients’ choice, when the switch has not been clearly justified or the switch has not been done during hospitalization; being regularly treated with long acting injectable atypical antipsychotics for at least 1 year after the initial use of long acting injectable atypical antipsychotics.

Exclusion Criteria

  • Patients that started long acting injectable atypical antipsychotics treatment as in-patients and patients that switched to long acting injectable atypical antipsychotics during hospitalization; patients with schizophrenia resistant to treatment.

Investigators

Sponsor
niversidade Federal de São Paulo - UNIFESP/EPM

Similar Trials

Observational study to assess data from... | Clinical Trial